Presentation TCT 2015 The Clinical Impact of Stroke With 2 Preventative Strategies: LAA Closure vs Chronic Oral Anticoagulation Presenter: Reda Ibrahim, Matthew J. Price, Vivek Y. Reddy October 11, 2015
Presentation TCT 2015 Debate: Is LAA Closure an Alternative to Oral Anticoagulation in Low Bleeding Risk Patients? Yes, LAA Closure Is at Least as Good as Oral Anticoagulation! Presenter: Reda Ibrahim, Matthew J. Price, Saibal Kar October 11, 2015
Presentation TCT 2015 Debate: Is LAA Closure an Alternative to Oral Anticoagulation in Low Bleeding Risk Patients? No, It Should Be Limited to Anticoagulation Contraindicated Patients! Presenter: Reda Ibrahim, Matthew J. Price, Jai-Wun Park October 11, 2015
Presentation 6 Months vs Extended Oral Anticoagulation After a First Episode of Pulmonary Embolism Presenter: Francis Couturaud July 10, 2015
Presentation Duration of Triple Therapy in Patients Requiring Oral Anticoagulation After DES Implantation Presenter: K.A. Fiedler April 22, 2015
Presentation Cardiovascular Interventions 2014 How to Manage Post PCI Antiplatelet Therapy in the Patient on Oral Anticoagulation Presenter: David P. Faxon October 23, 2014
Presentation TCT 2014 TCT 171: Avoidance of Major Bleeding with WATCHMAN Left Atrial Appendage Closure Compared with Long-term Oral Anticoagulation: A Pooled Analysis of Randomized Trials Presenter: Saibal Kar, Bushra S Rana, Jai-Wun Park, Matthew J. Price September 15, 2014
Presentation TCT 2014 Yes, It Is a Good Option for Most Anticoagulation Eligible Patients Presenter: Saibal Kar September 15, 2014
Presentation TCT 2014 No, It Should Be Limited to Patients with Absolute Anticoagulation Contraindications Presenter: Jai-Wun Park September 15, 2014
Presentation TCT 2013 Indications for Chronic Oral Anticoagulation After Primary PCI in STEMI and Recommended Regimens Presenter: Harvey White October 31, 2013
Presentation TCT 2013 Long term follow up of 134 patients with non valvular atrial fibrillation and contraindications to oral anticoagulation therapy, treated with the Ampatzer Cardiac Plug Device for LAA Presenter: Miroslava Stolcova October 29, 2013
Presentation TCT 2013 Triple Therapy (DAPT Plus Chronic Oral Anticoagulation): Risks and Therapeutic Alternatives Presenter: Eugenia Nikolsky October 28, 2013
Presentation TCT 2013 Current Use Patterns of Chronic Oral Anticoagulation: Penetration, Agent Selection, Complications, and Defining the Anticoagulant Ineligible Patient Presenter: Michael Ezekowitz October 27, 2013
Presentation Use and Associated Risks of Concomitant Aspirin with Oral Anticoagulation in A-fib Patients Presenter: B. A. Steinberg July 24, 2013
Presentation TVT 2013 Who Is Really Contraindicated for Oral Anticoagulation Therapy? Are There Absolute Guidelines? Presenter: Steven Goldberg June 15, 2013
Presentation Oral Anticoagulation (OAC) and Antiplatelets inA-fib Patients After MI and PCI Presenter: M. Lamberts June 12, 2013
Presentation LAA Closure with the Watchman Device in Patients with a Contraindication for Oral Anticoagulation Presenter: Vivek Y. Reddy April 09, 2013
Presentation PCI Outcomes 2013 DAPT + Oral Anticoagulation: Indications and Risk Amelioration Presenter: C. Michael Gibson March 07, 2013
Presentation TCT 2012 TCT-83. Watchman Left Atrial Appendage Closure in Atrial Fibrillation Patients with Contraindication to Oral Anticoagulation: the “Aspirin Plavix Registry” (ASAP) Presenter: Horst Sievert October 23, 2012
Presentation TCT 2012 Antithrombotic Strategies in Patients on Chronic Oral Anticoagulation Presenter: Ramon Quesada October 23, 2012